Loading
Latest filing published 29 Sept 2026 for Kura Oncology, Inc., €144k.
Brian Powl is a declared insider of Kura Oncology, Inc., with filings sourced from SEC (Form 4). In total, 3 filings cover trades dated from 21 August 2026 to 29 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 29 September 2026: a transaction of €144k, in Kura Oncology, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations